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Identity 
Other names: rhombotin 1, RBTN1, RHOM1, TTG1 
HGNC (Hugo): LMO1 
Location: 11p15.4 








4,4 kb (from the beginning of the 1st exon to the end of 
the 5th exon) consisting of 5 exons. 
Transcription 
mRNA of approximately 700 - 1000 bp, depending on 




LMO1 gene is located between RIC3 and STK33 genes in Chromosome 11p15. The arrow indicates the orientation of the genes. 
 
Structure of LMO1 gene. The gene consists of 5 exons and several splicing variants were reported. 
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Protein 
Description 
The protein contains two highly conserved, cysteine-
rich motifs known as LIM domains, which interact with 
other proteins. As LMO1 has no DNA-binding domain, 
its DNA binding ability is dependent on the other 
proteins with which it interacts. The proteins known for 
binding to LMO1 include TAL1/SCL and LDB1, and 
the molecules have an oncogenic function in T cell 
acute leukemia with the chromosomal translocation 
t(11;14)(p15;q11). 
Expression 
LMO1 expression is prominent in the central nervous 
system in both human and mouse. In mice it was 
observed by an in situ hybridization technique in the 
cerebral cortex, diencephalon, mesencephalon, 
cerebellum, myeloencephalon and spinal cord. 
Northern blot analysis revealed its expression in the 











Genome-wide association studies revealed a corelation 
between neuroblastoma and a single nucleotide 
polymorphism in LMO1 gene, rs110419 (A/G), of 
which the A allele was shown to promote LMO1 
expression and to corelate the cases. The DNA copy 
number gain of the LMO1 locus due to duplication was 
also demonstrated to associate with the cases. These 
findings suggest that the gene has a role in the 
development and/or progression of neuroblastoma. It 
was also reported that LMO3 is a neuroblastoma 
oncogene. 
Apoptosis of the gastric epithelial cells 
Note 
In some gastric-cancer derived cell lines, LMO1 is 
upregulated by TGFbeta signalling and induces their 
apoptosis through enhancing GSDMA expression. This 
TGFbeta-LMO1-GSDMA cascade is considered a 
mechanism for apoptosis induction in the gastric 




LMO1 induces apoptosis of the pit cells in TGFbeta signalling. 
This function is assumed to have a role in homeostasis of the 
gastric epithelium. 
T-cell acute lymphoblastic leukemia (T-
ALL) 
Disease 
Originally, the LMO1 gene was identified at a break 
point of the translocation t(11;14)(p15;q11), which was 
frequently observed in T-ALL. Using LMO1 as a 
probe, LMO2 and LMO3 were identified. LMO1 is 
expressed in inmature T cells but suppressed in the 
mature cells, and overexpression of the gene in  
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thymocytes, hematopoeitic progeniter cells located in 
the thymus, resulted in developing T-ALL in mice. 
LMO1 acts cooperatively with SCL (Stem cell 
leukemia) as a transcriptional activator or represser, 
dependent on the genes and the cells, and enforced 
expression of LMO1 and SCL in the thymocytes 
inhibits T-cell differentiation and causes T-ALL. It is 
known that the LMO1-SCL complex regulates several 
genes, including suppression of NFKB1 (nuclear factor 
of kappa light polypeptide gene enhancer in B-cells 1) 
and PTCRA (pre T-cell antigen receptor alpha), 
activation of NKX3.1 (NK3 homeobox 1). 
References 
McGuire EA, Hockett RD, Pollock KM, Bartholdi MF, O'Brien 
SJ, Korsmeyer SJ. The t(11;14)(p15;q11) in a T-cell acute 
lymphoblastic leukemia cell line activates multiple transcripts, 
including Ttg-1, a gene encoding a potential zinc finger protein. 
Mol Cell Biol. 1989 May;9(5):2124-32 
Boehm T, Foroni L, Kaneko Y, Perutz MF, Rabbitts TH. The 
rhombotin family of cysteine-rich LIM-domain oncogenes: 
distinct members are involved in T-cell translocations to human 
chromosomes 11p15 and 11p13. Proc Natl Acad Sci U S A. 
1991 May 15;88(10):4367-71 
Boehm T, Spillantini MG, Sofroniew MV, Surani MA, Rabbitts 
TH. Developmentally regulated and tissue specific expression 
of mRNAs encoding the two alternative forms of the LIM 
domain oncogene rhombotin: evidence for thymus expression. 
Oncogene. 1991 May;6(5):695-703 
McGuire EA, Rintoul CE, Sclar GM, Korsmeyer SJ. Thymic 
overexpression of Ttg-1 in transgenic mice results in T-cell 
acute lymphoblastic leukemia/lymphoma. Mol Cell Biol. 1992 
Sep;12(9):4186-96 
Ono Y, Fukuhara N, Yoshie O. TAL1 and LIM-only proteins 
synergistically induce retinaldehyde dehydrogenase 2 
expression in T-cell acute lymphoblastic leukemia by acting as 
cofactors for GATA3. Mol Cell Biol. 1998 Dec;18(12):6939-50 
 
Valge-Archer V, Forster A, Rabbitts TH. The LMO1 and LDB1 
proteins interact in human T cell acute leukaemia with the 
chromosomal translocation t(11;14)(p15;q11). Oncogene. 1998 
Dec 17;17(24):3199-202 
Herblot S, Steff AM, Hugo P, Aplan PD, Hoang T. SCL and 
LMO1 alter thymocyte differentiation: inhibition of E2A-HEB 
function and pre-T alpha chain expression. Nat Immunol. 2000 
Aug;1(2):138-44 
Aoyama M, Ozaki T, Inuzuka H, Tomotsune D, Hirato J, 
Okamoto Y, Tokita H, Ohira M, Nakagawara A. LMO3 interacts 
with neuronal transcription factor, HEN2, and acts as an 
oncogene in neuroblastoma. Cancer Res. 2005 Jun 
1;65(11):4587-97 
Chang PY, Draheim K, Kelliher MA, Miyamoto S. NFKB1 is a 
direct target of the TAL1 oncoprotein in human T leukemia 
cells. Cancer Res. 2006 Jun 15;66(12):6008-13 
Saeki N, Kim DH, Usui T, Aoyagi K, Tatsuta T, Aoki K, 
Yanagihara K, Tamura M, Mizushima H, Sakamoto H, Ogawa 
K, Ohki M, Shiroishi T, Yoshida T, Sasaki H. GASDERMIN, 
suppressed frequently in gastric cancer, is a target of LMO1 in 
TGF-beta-dependent apoptotic signalling. Oncogene. 2007 Oct 
4;26(45):6488-98 
Kusy S, Gerby B, Goardon N, Gault N, Ferri F, Gérard D, 
Armstrong F, Ballerini P, Cayuela JM, Baruchel A, Pflumio F, 
Roméo PH. NKX3.1 is a direct TAL1 target gene that mediates 
proliferation of TAL1-expressing human T cell acute 
lymphoblastic leukemia. J Exp Med. 2010 Sep 
27;207(10):2141-56 
Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, 
Schnepp RW, Diamond M, Bosse K, Mayes PA, Glessner J, 
Kim C, Frackelton E, Garris M, Wang Q, Glaberson W, 
Chiavacci R, Nguyen L, Jagannathan J, Saeki N, Sasaki H, 
Grant SF, Iolascon A, Mosse YP, Cole KA, Li H, Devoto M, 
McGrady PW, London WB, Capasso M, Rahman N, 
Hakonarson H, Maris JM. Integrative genomics identifies 
LMO1 as a neuroblastoma oncogene. Nature. 2011 Jan 
13;469(7329):216-20 
This article should be referenced as such: 
Saeki N, Sasaki H. LMO1 (LIM domain only 1 (rhombotin 1)). 
Atlas Genet Cytogenet Oncol Haematol. 2012; 16(2):84-86. 
